Article
Homologous mutations near the junction of the sixth transmembrane domain and the third extracellular loop lead to constitutive activity and enhanced agonist affinity at all muscarinic receptor subtypes.
The Journal of pharmacology and experimental therapeutics - 1 Mar 2002
Ford Diane J, Essex Anthony, Spalding Tracy A, Burstein Ethan S, Ellis John
Abstract excerpt
Previous studies have found that a mutation near the junction of the sixth transmembrane domain (TM6) and the third extracellular loop of the M5 muscarinic receptor leads to constitutive activation and enhanced agonist affinity for the mutated receptor. These results were consistent with the extended ternary complex model, which predicts a correlation between agonist affinity and constitutive activity. We have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
